Table 4.
Usage of antiepileptic drugs based on the annual number of awake craniotomies
| Preoperative AED | Awake craniotomies <10 (26) | Awake craniotomies ≥10 (13) | ||
|---|---|---|---|---|
| All patients | 19 (73%) | 7 (54%) | ||
| Selective | 6 (23%) | 6 (46%) | ||
| None | 1 (4%) | 0 (0%) | ||
| No epileptic history | Epileptic history | No epileptic history | Epileptic history | |
| LEV | 17 | 25 | 7 | 13 |
| LCM | 2 | 10 | 1 | 4 |
| LTG | 1 | 2 | 0 | 1 |
| PER | 0 | 4 | 1 | 2 |
| New type AEDs | 20 (74%) | 41 (69%) | 9 (100%) | 20 (95%) |
| PHT (fosPHT) | 3 | 5 | 0 | 0 |
| VPA | 3 | 4 | 0 | 0 |
| CBZ | 1 | 9 | 0 | 1 |
| Old type AEDs | 7 (26%) | 18 (31%) | 0 (0%) | 1 (5%) |
| Intraoperative AED | Awake craniotomies <10 (26) | Awake craniotomies ≥10 (13) | ||
| All patients | 18 (69%) | 4 (31%) | ||
| Selective | 2 (8%) | 2 (15%) | ||
| None | 6 (23%) | 7 (54%) | ||
| No epileptic history | Epileptic history | No epileptic history | Epileptic history | |
| LEV | 6 | 9 | 1 | 2 |
| LCM | 0 | 1 | 0 | 0 |
| LTG | 0 | 0 | 0 | 0 |
| PER | 0 | 0 | 0 | 0 |
| New type AEDs | 6 (32%) | 10 (50%) | 1 (25%) | 2 (33%) |
| PHT (fosPHT) | 13 | 10 | 3 | 4 |
| VPA | 0 | 0 | 0 | 0 |
| CBZ | 0 | 0 | 0 | 0 |
| Old type AEDs | 13 (68%) | 10 (50%) | 3 (75%) | 4 (67%) |
| Postoperative AED | Awake craniotomies <10 (26) | Awake craniotomies ≥10 (13) | ||
| All patients | 13 (50%) | 7 (54%) | ||
| Selective | 13 (50%) | 6 (46%) | ||
| None | 0 (0%) | 0 (0%) | ||
| No epileptic history | Epileptic history | No epileptic history | Epileptic history | |
| LEV | 13 | 25 | 6 | 12 |
| LCM | 4 | 15 | 3 | 5 |
| LTG | 2 | 2 | 0 | 0 |
| PER | 1 | 6 | 2 | 5 |
| New type AEDs | 20 (77%) | 48 (83%) | 11 (85%) | 22 (92%) |
| PHT (fosPHT) | 2 | 2 | 1 | 1 |
| VPA | 2 | 4 | 0 | 0 |
| CBZ | 2 | 4 | 1 | 1 |
| Old type AEDs | 6 (23%) | 10 (17%) | 2 (15%) | 2 (8%) |
AED: antiepileptic drug